stay updated with our newsletter

L-Theanine: Clinical Benefits, Uses, Dosage and Practitioner Considerations

L-theanine is a non-protein amino acid found naturally in the leaves of Camellia sinensis, the plant used to produce green, black, white and oolong tea. Structurally similar to glutamate, L-theanine has attracted clinical interest because of its potential to promote relaxation, improve aspects of attention and cognitive performance, and support sleep without producing the degree of sedation associated with many conventional sleep or anxiolytic agents.

Although tea provides L-theanine naturally, typical amounts are relatively modest and vary substantially with tea variety and preparation. Clinical studies generally use isolated L-theanine in doses substantially higher than those obtained from a single cup of tea.

Recent systematic reviews and randomized controlled trials suggest that L-theanine may be particularly useful when the clinical goal is not simply sedation, but a state of reduced stress accompanied by preserved or potentially improved cognitive function.1234 This combination makes L-theanine an interesting option for patients experiencing stress-related sleep difficulties, mental fatigue or impaired concentration.

Mechanisms of Action

L-theanine is absorbed in the small intestine and can cross the blood-brain barrier. Human pharmacokinetic studies indicate that plasma concentrations rise relatively rapidly after oral administration, with peak concentrations generally occurring within approximately an hour.

Its neurological effects appear to involve several complementary pathways. L-theanine is structurally related to glutamate and may influence glutamatergic neurotransmission while also modulating other neurotransmitter systems involved in relaxation, mood and attention. Preclinical evidence suggests effects involving GABA, dopamine, glycine and serotonin signaling, although the clinical importance of individual pathways remains uncertain.5

One of L-theanine’s most frequently discussed neurological effects is its association with increased alpha-frequency brain activity. Alpha activity is generally associated with a relaxed but wakeful mental state. This provides a plausible physiological explanation for an effect patients sometimes describe as feeling calmer without feeling substantially sedated.

The distinction is clinically important: L-theanine should not necessarily be conceptualized as a conventional sedative. Its potential benefit may instead involve reducing excessive arousal while maintaining functional attention.

Stress and Relaxation

Stress reduction is one of the most common reasons L-theanine is used clinically.

Randomized studies suggest that doses in the range of approximately 200-400 mg/day may reduce some subjective measures of stress. In a four-week randomized, placebo-controlled crossover trial, 30 healthy adults received 200 mg/day of L-theanine. Investigators reported improvements in measures of stress-related symptoms, including anxiety-related scores and sleep quality.2

More recently, a randomized, double-blind, placebo-controlled trial evaluated 400 mg/day of L-theanine for 28 days in healthy adults experiencing moderate stress. Participants receiving L-theanine demonstrated improvements in perceived stress and some measures of cognitive attention and sleep quality. Importantly, however, changes in salivary cortisol were not significant, and investigators noted evidence of a placebo response.3

These findings suggest that L-theanine may be useful for patients experiencing subjective psychological stress or heightened arousal, but practitioners should avoid presenting it as a treatment for anxiety disorders.

Indeed, clinical evidence in generalized anxiety disorder remains limited. An eight-week randomized trial evaluating L-theanine as an adjunct to stable antidepressant therapy did not demonstrate a significant improvement in Hamilton Anxiety Rating Scale scores compared with placebo.5

Therefore, the evidence is stronger for stress management in otherwise healthy or moderately stressed individuals than for treating established anxiety disorders.

Sleep Support

L-theanine may also be useful for patients whose sleep problems are associated with stress, cognitive arousal or difficulty transitioning into sleep.

A 2025 systematic review and meta-analysis evaluated 19 studies involving 897 participants, with 18 studies included in the quantitative analysis. L-theanine-containing interventions produced statistically significant improvements in subjective sleep onset latency, daytime dysfunction and overall subjective sleep quality.6

The magnitude of benefit was generally modest, and an important limitation is that not every study evaluated isolated L-theanine. Some investigated combinations containing other active ingredients. Consequently, the optimal dose and duration for sleep remain uncertain.

Nevertheless, the available evidence suggests a potentially useful clinical distinction between L-theanine and traditional sedatives. Rather than strongly inducing sleep, L-theanine may facilitate sleep by reducing the cognitive and physiological arousal that interferes with sleep initiation and quality.

For patients who describe being physically tired but mentally “wired,” this mechanism may be particularly relevant.

Attention and Cognitive Performance

The cognitive literature surrounding L-theanine is increasingly interesting.

A systematic review and meta-analysis of randomized trials examining tea, L-theanine and L-theanine combined with caffeine found evidence of small-to-moderate improvements in selected measures of attention and reaction time. The combination of L-theanine and caffeine produced some of the most consistent effects, particularly during the first several hours after ingestion.4

A newer meta-analysis of randomized trials likewise concluded that L-theanine appears to provide a relatively robust short-term benefit for attention in healthy adults, while effects on anxiety and several other psychological outcomes were less consistent.1

The caffeine combination deserves particular attention. Caffeine can improve vigilance and alertness but may also produce jitteriness, increased sympathetic activation or subjective anxiety in sensitive individuals. L-theanine appears capable of modifying the cognitive experience associated with caffeine while preserving – or potentially enhancing – attention.

In a controlled study involving sleep-deprived young adults, 200 mg L-theanine combined with 160 mg caffeine improved reaction time, target discrimination and electrophysiological measures of selective attention compared with placebo.7

For practitioners, this suggests a potential application for patients seeking cognitive support who tolerate caffeine but experience excessive stimulation from caffeine alone.

Potential Clinical Uses

Stress-related tension: particularly when the goal is relaxation without substantial daytime sedation.

Sleep support: especially when difficulty falling asleep appears related to mental arousal or stress.

Attention and concentration: acute L-theanine may modestly improve selected measures of attention.

Caffeine optimization: combining L-theanine with caffeine may provide more balanced cognitive stimulation for some individuals.

Stress-associated cognitive impairment: patients reporting difficulty concentrating during periods of elevated stress may represent a particularly relevant population.

L-theanine has also been investigated as an adjunct in psychiatric conditions including schizophrenia, ADHD, major depressive disorder, obsessive-compulsive disorder and generalized anxiety disorder. A 2024 systematic review identified 11 randomized trials across several psychiatric conditions and reported encouraging findings in some populations.8 However, heterogeneity among disorders, interventions and outcomes makes broad clinical conclusions premature.

L-theanine should therefore not be considered a substitute for evidence-based treatment of psychiatric disorders.

Dosing Considerations

Human clinical trials commonly use approximately 100-400 mg/day, although protocols vary according to indication.

For daytime relaxation or acute cognitive applications, 100-200 mg is frequently studied. When combined with caffeine, studies often use approximately 100-200 mg of L-theanine, although caffeine doses vary considerably.

For ongoing stress or sleep support, clinical trials have used approximately 200-400 mg/day, sometimes divided into multiple doses.

Because L-theanine’s effects may appear relatively quickly, practitioners can often individualize dosing based on response rather than assuming that higher doses will necessarily produce greater benefits.

Safety and Practitioner Considerations

L-theanine has generally demonstrated a favorable safety profile in human studies. Recent systematic reviews and controlled trials have reported few serious tolerability concerns at commonly studied doses.138 L-theanine has also been the subject of FDA Generally Recognized as Safe (GRAS) notifications for use as a food ingredient.9

Nevertheless, dietary-supplement use warrants the same clinical considerations applied to other bioactive compounds. Practitioners should review concurrent medications, pregnancy or lactation status, underlying medical conditions and individual sensitivity. Because relaxation and possible blood-pressure effects may occur in some individuals, additional caution may be reasonable in patients taking antihypertensive or sedating medications.

Product quality also matters. Clinical research generally uses defined quantities of purified L-theanine, whereas commercial supplements may differ in purity, dose accuracy and formulation.

Clinical Perspective

L-theanine occupies an unusual position among compounds used for stress and cognitive support. Rather than functioning primarily as either a stimulant or a sedative, it appears to influence the balance between relaxation and attention.

The strongest emerging clinical rationale is therefore not that L-theanine “treats anxiety” or “induces sleep,” but that it may help regulate excessive arousal while preserving cognitive performance.

Current evidence supports potential benefits for perceived stress, selected aspects of sleep quality and attention, with particularly interesting results when L-theanine is combined with caffeine. At the same time, effect sizes are generally modest, trials remain relatively small and results vary among populations.

For practitioners, L-theanine is best viewed as a generally well-tolerated adjunctive option for stress-related symptoms, sleep support and cognitive performance, rather than a primary treatment for psychiatric or sleep disorders.

Related:

L-Theanine: Patient Selection Guide

 

References

  1. Fond G, et al. Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis of 31 randomized trials. 2026. PubMed.
  2. Hidese S, et al. Effects of L-Theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial. Nutrients. 2019;11(10):2362.
  3. Williams JL, et al. Safety and efficacy of AlphaWave L-Theanine supplementation for 28 days in healthy adults with moderate stress: a randomized, double-blind, placebo-controlled trial. Neurol Ther. 2024.
  4. Payne ER, Aceves-Martins M, Dubost J, Greyling A, de Roos B. Effects of tea (Camellia sinensis) or its bioactive compounds L-theanine or L-theanine plus caffeine on cognition, sleep, and mood in healthy participants: a systematic review and meta-analysis of randomized controlled trials.
  5. New and emerging treatments for anxiety disorders. BMJ. 2026;392:e083441.
  6. The effects of L-theanine consumption on sleep outcomes: a systematic review and meta-analysis. Sleep Med Rev. 2025;81:102076.
  7. High-dose L-theanine-caffeine combination improves neurobehavioural and neurophysiological measures of selective attention in acutely sleep-deprived young adults: a double-blind, placebo-controlled crossover study. 2025.
  8. Moshfeghinia R, Sanaei E, Mostafavi S, et al. The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review. BMC Psychiatry. 2024;24:886.
  9. U.S. Food and Drug Administration. GRAS Notice No. 501: L-theanine (chemically synthesized).